clinical trials

Why The Magenta Therapeutics (MGTA) Stock Plummeted Over 50%
Pulse 2.0
Wed, 12/21/22 - 11:27 am
Magenta Therapeutics
clinical trials
MGTA-117
AML
myelodysplastic syndrome
FDA approves Skye Bioscience’s IND for glaucoma therapy trial
Clinical Trials Arena
Wed, 12/21/22 - 11:20 am
Skye Bioscience
clinical trials
SBI-100
glaucoma
Vaxess' flu vaccine patch passes early clinical test, clearing path for further development
Fierce Pharma
Tue, 12/20/22 - 11:05 am
Vaxess
clinical trials
vaccines
Flu
flu vaccines
vaccine patches
CuraSen reports positive data from Parkinson’s disease oral therapy trial
Clinical Trials Arena
Tue, 12/20/22 - 10:58 am
CuraSen
clinical trials
CST-103
Parkinson's Disease
Fresh from Vertex payday, Entrada's DMD plans are derailed by FDA hold
Fierce Biotech
Tue, 12/20/22 - 10:42 am
Entrada Therapeutics
Vertex Pharmaceuticals
FDA
clinical trials
Duchenne Muscular Dystrophy
myotonic muscular dystrophy
ENTR-601-44
Medtronic starts US robotic surgery trial in push to challenge Intuitive
Medtech Dive
Tue, 12/20/22 - 10:39 am
devices
Medtech
Medtronic
robotic surgery
Hugo
urology
clinical trials
Biotech’s key upcoming clinical results
EP Vantage
Tue, 12/20/22 - 10:27 am
clinical trials
Acadia Pharmaceuticals
Argenx
Arrowhead Pharmaceuticals
Biomarin
BioNTech
Daiichi Sankyo
Day One
EQRx
Fate Therapeutics
FibroGen
Gilead Sciences
Idorsia
Immunogen
Intellia Therapeutics
Karuna Therapeutics
Moderna Therapeutics
Regeneron
Roche
Travere Therapeutics
Vaxcyte
Madrigal shares triple on positive NASH study results
BioPharma Dive
Mon, 12/19/22 - 12:22 pm
Madrigal Pharmaceuticals
clinical trials
NASH
resmetirom
Bionomics' lead asset fails to reduce public speaking anxiety in phase 2 trials
Fierce Biotech
Mon, 12/19/22 - 11:10 am
Bionomics
BNC210
clinical trials
anxiety
public speaking anxiety
Synaptogenix reports disappointing data from Phase II Alzheimer’s trial
Clinical Trials Arena
Mon, 12/19/22 - 11:08 am
Synaptogenix
clinical trials
NIH
Alzheimer's disease
Bryostatin-1
FDA Lifts Partial Clinical Hold On Bluebird Bio's Sickle Cell Disease Studies
NASDAQ
Mon, 12/19/22 - 10:59 am
Bluebird Bio
FDA
clinical trials
lovo-cel
sickle cell disease
Frequency doses first patient in Phase Ib sensorineural hearing loss trial
Clinical Trials Arena
Fri, 12/16/22 - 10:56 am
Frequency Therapeutics
FX-345
clinical trials
sensorineural hearing loss
Dr. Reddy's subsidiary hits the pause button on drug development for psoriasis
Endpoints
Fri, 12/16/22 - 10:32 am
Dr Reddy's
psoriasis
Aurigene
clinical trials
AUR101
Astellas’ Phase III gastric cancer therapy trial meets primary endpoint
Clinical Trials Arena
Fri, 12/16/22 - 10:21 am
Astellas
clinical trials
zolbetuximab
gastric cancer
Third Harmonic, latest victim of raised liver enzymes, shutters trial and sees shares slide
Fierce Biotech
Fri, 12/16/22 - 10:20 am
Third Harmonic Bio
liver enzymes
clinical trials
THB001
chronic inducible urticaria
Diamyd Diabetes Vaccine Study gets Green Light to Resume by the FDA
Xtalks
Thu, 12/15/22 - 11:07 pm
Diamyd Medical
type 1 diabetes
FDA
clinical trials
Diamyd
ASH: Bristol's 3rd-line Abecma data didn't make the trip to New Orleans. Is it cause for concern?
Fierce Pharma
Mon, 12/12/22 - 10:59 pm
Bristol Myers Squibb
ASH 2022
Abecma
clinical trials
Multiple Myeloma
Brand Institute Outlines the Benefits of Early Clinical Trial Branding
Pharm Exec
Mon, 12/12/22 - 10:49 pm
clinical trials
clinical trial branding
Brand Institute
AstraZeneca-Daiichi Sankyo’s therapy shows response in breast cancer trials
Clinical Trials Arena
Mon, 12/12/22 - 10:26 am
AstraZeneca
Daiichi Sankyo
clinical trials
datopotamab deruxtecan
metastatic triple-negative breast cancer
breast cancer
Broken promises? FDA needs more power to remove drugs from marketplace, JAMA analysis finds
Endpoints
Sun, 12/11/22 - 01:22 pm
JAMA
FDA
clinical trials

Pages